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TO THE EDITOR
Recent studies revealed that dermal
fibroblasts undergo morphological
changes and cell body collapse in both
chronically aged and photoaged skin
(Varani et al., 2004, 2006; Fisher et al.,
2008). Together with the loss of func-
tional collagen matrix, these alterations
can contribute to the development of
coarse, rough, and wrinkled appear-
ance, which are characteristics of aged
skin (Fisher et al., 2008). Collagen
degradation and altered integrin/focal
adhesion molecules could be key fac-
tors that lead to cell body collapse due
to the loss of mechanical tension
between fibroblast and the matrix
(Varani et al., 2004, 2006; Fisher
et al., 2008). These abnormal fibro-
blasts in aged skin have a lower rate of
proliferation and reduced capability to
produce collagen matrix, which can
contribute to or worsen the signs of
aging (Varani et al., 2006). Restoration
of the cell–matrix connection and
improvement in cell mechanical ten-
sion in the dermis remains an area of
interest for antiaging skin care research.
In this current study, we revealed
the critical role of a key focal
adhesion molecule, paxillin, in aging
of human skin.
Integrins and their downstream
focal adhesion molecules regulate the
bidirectional signaling between cell
and extracellular matrix (ECM; Qin
et al., 2004; Wolfenson et al., 2009).
Over 100 proteins have been detected
localized or associated with the focal
adhesion complexes, and many of them
are known to modulate important cel-
lular functions (Zamir and Geiger,
2001; Karako¨se et al., 2010). Among
focal adhesion molecules, paxillin is an
important adaptor protein that mediates
integrin and growth factor signaling. It
transduces the messages from ECM,
recruits focal adhesion molecules, and
activates intracellular cytoskeleton as-
sembly (Deakin and Turner, 2008). This
process is critical for cell attachment,
spreading, and migration (Webb et al.,
2003). Paxillin-mediated signaling also
promotes cell proliferation and regu-
lates ECM organization, which is key to
wound repair and tissue regeneration
(Lee and Gotlieb, 1999; Zhou et al.,
1999). Loss of paxillin activity has been
related to impaired cellular function in
various animal and cell models (Hagel
et al., 2002; Nishio and Inoue, 2005;
Hao et al., 2006). Paxillin was demon-
strated to be essential for mouse em-
bryonic development and fibronectin
signaling (Hagel et al., 2002). In human
studies, Caltagarone et al. (2010) dis-
covered alteration in paxillin protein
level, distribution, and phosphorylation
in Alzheimer’s disease brain, suggesting
that this focal adhesion component
could be implicated during brain aging
and neurodegeneration. However, a
direct link between paxillin and aging
of human skin is yet to be established.
On the basis of the previous research on
morphology disruption in aged fibro-
blast and ECM degradation, as well as
the critical function of paxillin, we
hypothesize that paxillin could be a
key regulator for fibroblast morphology
and cell mechanical properties, and
can have an important role during
skin aging.
To better understand the role of
paxillin in skin aging, we first investi-
gated the expression levels of paxillin
protein in human dermal fibroblasts
from young and aged donors (n¼7 for
young, n¼ 6 for aged). A significant
decrease of paxillin was found in aged
fibroblasts by western blot analysis, and
quantification of the immunoblots sug-
gests an average of 28.7% reduction in
aged cells (Figure 1a). Immunofluores-
cence staining of dermal fibroblasts
using paxillin antibody further supports
the western blot data where a reduction
of punctuate focal adhesion localiza-
tion was observed in aged cells
(Figure 1b).
To mimic the effect of paxillin loss in
aged fibroblasts and to better under-
stand the consequence, experiments
were conducted by knocking down
paxillin protein in fibroblasts from both
young and aged donors using specific
small interfering RNA. Knockdown
(KD) efficiency was confirmed at both
gene (data not shown) and protein
levels (Supplementary Figure S1 online).
A significant disruption of cell morphol-
ogy was found 48 hours post trans-
fection. Instead of being fully spread
out and adherent to the ECM through
abundant focal adhesion points, the
KD cells lost the majority of focal
contacts to matrix and had a shrun-
ken appearance with thin and
elongated protrusions (Figure 1c). A
significant reduction of cell surface
areas was observed in KD fibroblasts
measured using ImageJ (NIH, Bethesda,
MD) (Figure 1d). Hagel et al. (2002)
studied paxillin / mouse embryonic
fibroblasts plated on fibronectin, and
discovered abnormality in focal adhe-
sion morphology and cortical cytoskel-
eton structures. In our studies, the
changes observed in adult dermal
fibroblasts with paxillin KD were simi-
lar but more severe. There was a
significant reduction in the density of
focal adhesion and actin cytoskeleton,
as well as abnormality in cell morphol-
ogy. Disruption of fibroblast morphol-
ogy is a key indication of loss of cell
function and productivity (Varani et al.,
2006). Therefore, our data strongly
support the hypothesis that, in addition
to collagen, paxillin can be a critical
intracellular component in building the
communication between dermal fibro-
blasts and ECM, and maintaining
healthy adherent cell morphology that
is key to skin productivity as suggested
by Varani et al. (2006).
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Abbreviations: ECM, extracellular matrix; KD, knockdown
To further investigate how loss of
paxillin could contribute to skin aging,
functional assays on collagen produc-
tion and matrix contractility were per-
formed. Dermal fibroblasts with
paxillin KD showed a significant reduc-
tion in secreted procollagen-1 level,
suggesting a loss of cell productivity
(Figure 2a). As focal adhesion can be
a direct mediator of transduction of
mechanical stimulation signals (Varani
et al., 2004, 2006), we proposed that,
as a key adaptor between ECM, focal
adhesion, and cytoskeleton, paxillin
contributes to the mechanical tension
between fibroblasts and its matrix. To
validate such a hypothesis, fibroblast
contractility assay was performed using
paxillin KD cells. Normal fibroblasts
showed over 60% contraction in col-
lagen gel, whereas KD cells failed to
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Figure 1. Paxillin is important for dermal fibroblast
morphology and declines with age. (a) Paxillin
protein level decreases with age in human dermal
fibroblasts. Western blot of fibroblasts lysate from
young and aged donors. Left upper: anti-paxillin; left
lower: anti-GAPDH (glyceraldehyde-3-phosphate
dehydrogenase). Picture shown is representative
of six individual experiments. Right: quantification
of immunoblots of human dermal fibroblasts from
young and aged donors. Intensity of protein bands
were quantified by Image J. Paxillin protein expres-
sion level was normalized against GAPDH. An
average of 28.7% reduction in Paxillin level was
found in cells from aged donors. Graph shown is
average of six experiments (young, 16–25 years old,
n¼ 7; aged, 52–77 years old, n¼6; *Po0.05).
(b) Immunocytochemistry of human dermal fibro-
blasts from young (left) and older (right) donors.
Arrowheads: paxillin staining at focal adhesion.
Upper: anti-paxillin-FITC staining; lower: merge
of FITC with rhodamine–phalloidin staining. Pictures
are representatives from three individual experi-
ments. Bar¼ 20 mm. (c) Paxillin knockdown by
small interfering RNA (SiRNA) disrupts cell mor-
phology. Reduction in cell spreading and abnormal
cell shape with thin, elongated protrusions was
observed. Phalloidin staining is used for visualizing
actin cytoskeleton structure. Reduction in focal
adhesion sites and density of actin filaments was
observed. Bar¼ 20mm. Green/FITC: anti-paxillin;
red/rhodamine: phalloidin. Arrows: punctuated
paxillin staining concentrated at cell edges. Arrow-
heads: disrupted cell morphology after paxillin
SiRNA knockdown. Data shown here are represen-
tatives from experiments using cells from young
donors; similar results were observed in experiments
using cells from aged donors (data not shown).
(d) Reduction in cell surface area measurement after
paxillin SiRNA knockdown. Five 20 fluorescent
images from each condition transfected with either
paxillin SiRNA or control SiRNA were imported into
ImageJ, and 10 cells from each image were
randomly selected. Cell surface regions were
measured using the ImageJ area measurement tool.
Cell surface area was significantly reduced after
paxillin SiRNA knockdown compared with the
control (*Po0.05).
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contract appropriately compared with
their vehicle control (Figure 2b and c).
These data suggest that significant
changes in dermal structure and integ-
rity can occur with paxillin loss, which
in turn could lead to signs of aging such
as rhytides and laxity.
Taken together, our data help ex-
plain the critical role of paxillin in
maintaining dermal structure and cel-
lular function. The fact that paxillin is
directly associated with key factors
contributing to skin aging, such as
collagen production and mechanical
tension, is previously unreported to
our knowledge. Healthy collagen ma-
trix and collagen-mediated signaling is
essential to dermal fibroblast prolifera-
tion and productivity as indicated by
Varani et al. (2006). In addition to this,
our findings suggest that paxillin also
has a crucial role in dermal function
through regulating cell adhesion and
spreading, assuring mechanical con-
nection between the cell and matrix,
and maintaining cell productivity and
dermal structure. With age, the loss of
paxillin could compromise skin cell
function as stated above, resulting in
the appearance or worsening of skin
aging. Reestablishment of the cell–
matrix connection and restoration of
fibroblast morphology through colla-
gen stimulation or hyaluronan injection
have been proven effective in fighting
clinical aging signs (Fisher et al., 2008).
Meanwhile, the equally important in-
tracellular components should not be
overlooked. Here we report paxillin as
a new antiaging target, and our data
suggest that it can serve as a key
regulator in dermal fibroblast morphol-
ogy and function. Besides paxillin,
integrins and downstream focal adhe-
sion signaling molecules have important
roles in regulating cellular activities;
their changes and contribution during
skin aging should also be taken into
consideration. Further investigation on
signaling pathways mediated by pax-
illin and other focal adhesion mole-
cules, and their role in mechanical
stimulation and aging, is recommended
to better understand such complex
mechanisms.
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Figure 2. Paxillin is critical for dermal fibroblast collagen production and mechanical property.
(a) Reduction of ProCollagen-I production by paxillin small interfering RNA (SiRNA). Dermal fibroblasts
were transfected with control or paxillin SiRNA, respectively, and incubated at 37 1C. Conditioned medium
was collected 72 hours after transfection was completed. ProCollagen-I level was measured by ELISA.
Significant reduction of ProCollagen-I protein level was observed under either serum-free conditions (data
not shown) or in a medium containing 2% serum, suggesting that paxillin is critical for cellular production
of Collagen-I. (*Po0.05). (b) Reduction of ECM contractility by paxillin knockdown. Collagen gel
contractility assay was performed with control and paxillin SiRNA–transfected dermal fibroblasts. Cells
were transfected as described above, and collagen gel was prepared following the manufacturer’s protocol.
Images were taken 72 hours after transfected cells were loaded into collagen gel. Upper panel—control
SiRNA; lower panel—paxillin SiRNA. (c) Quantification of collagen gel size. Surface area of each collagen
gel was measured using the ImageJ area measurement tool. Results are expressed as percentage of gel
size at 0 hour. Control cells exhibit over 60% reduction in gel size, whereas paxillin SiRNA–transfected
cells showed significant reduced gel contractility, suggesting a decrease in mechanical tension between
dermal fibroblasts and extracellular matrix (*Po0.05). (d) Illustration on the proposed role of paxillin
during skin aging. Reduction of paxillin with age could lead to loss of cell–matrix connection and commu-
nication, as well as dysregulation of cytoskeleton support to cell; both can contribute to decreased
extracellular matrix production and disrupted mechanical property in skin.
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Histone Deacetylase 2 Is Upregulated in Normal and
Keloid Scars
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TO THE EDITOR
Repair following cutaneous injury is
essential to return function, form, and
integrity to the tissue. Scar formation is
the inevitable and currently unprevent-
able consequence of tissue damage,
and misregulation can lead to the
development of pathological scarring
as in hypertrophic and keloid scars.
In developed countries alone, approxi-
mately 100 million people each year
will be left with a scar following sur-
gery; moreover, there are thought to be
11 million people with keloid scars
(Sund, 2000). This represents a signi-
ficant burden to both health-care pro-
viders and individuals.
Currently, the pathogenesis of keloid
scars is not fully understood, but there
are a number of clues as to the etiology.
There is an obvious genetic component,
and they have also been linked to
hormonal influences, wound infection,
and skin tension (Wolfram et al., 2009).
Given the burden presented and our
current poor ability to reduce or prevent
normal and pathological scarring,
clearly an improved understanding of
the molecular mechanisms underlying
scar formation is essential, and research
into novel treatment strategies is justi-
fied.
Histone deacetylases (HDACs) and
counteracting histone acetyltransferases
(HATs) are epigenetic modifying en-
zymes that are accepted to, respec-
tively, remove and add acetyl groups to
histones, and in this manner influence
gene expression (acetylation is gener-
ally an activating, transcription-promot-
ing modification; Kuo and Allis, 1998).
The objective of this work was to
characterize the expression profiles of
specific HDACs in normal and keloid
scars; this has not been previously
investigated, and there is a lack of
consensus about the role of histone
(de)acetylation in various fibrotic con-
ditions. For example, HDAC inhibitors
used in vitro suppressed myofibroblast
differentiation (Glenisson et al., 2007;
Mannaerts et al., 2010) and decreased
collagen production in keloid fibro-
blasts (Diao et al., 2011); in animal
models, HDAC inhibition decreased
heart, kidney, and liver fibrosis (Pang
et al., 2009; Iyer et al., 2010; Marumo
et al., 2010). Conversely, HATs were
overexpressed in fibrotic lesions of
scleroderma patients (Bhattacharyya
et al., 2005), and HAT inhibition was
found to be anti-fibrotic (Li et al., 2008).
To investigate HDAC expression in
human skin scars, three types of skin tissue
were assessed by immunohistochemistry
(IHC): normal human skin, normal scar
Abbreviations: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HAT, histone acetyltransferase;
HDAC, histone deacetylase; IHC, immunohistochemistry; TGFb, transforming growth factor-b
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